Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash provided by (used for) operating activities
Net income (loss)	$ 527	$ (137)
Gain on disposal of businesses	(8)	0
Depreciation and amortization	531	552
Deferred and prepaid income taxes	(88)	15
Stock-based compensation expense	94	88
Intangible asset impairment charges	45	233
Net loss (gain) on investments and notes receivable	(22)	34
Contingent consideration net expense (benefit)	(91)	(108)
Inventory step-up amortization	8	30
Foreign exchange (gain) loss	9	12
Other, net	26	35
Trade accounts receivable	(145)	365
Inventories	(100)	(36)
Other assets	(200)	(179)
Accounts payable and accrued expenses	187	(531)
Other liabilities	153	(181)
Cash provided by (used for) operating activities	927	192
Investing activities:
Purchases of property, plant and equipment	(181)	(168)
Proceeds from sale of property, plant and equipment	7	4
Payments for acquisitions of businesses, net of cash acquired	(706)	(3)
Proceeds from royalty rights	43	45
Payments for investments and acquisitions of certain technologies	(30)	(29)
Proceeds from sale of investments	122	0
Proceeds from disposal of businesses	801	15
Payments for Hedge, Investing Activities	15	0
Cash provided by (used for) investing activities	71	(135)
Financing activities:
Payment of contingent consideration previously established in purchase accounting	(14)	(38)
Payments for royalty rights	(42)	(52)
Payments on short-term borrowings	0	(2,700)
Proceeds from short-term borrowings, net of debt issuance costs	0	2,245
Net increase (decrease) in commercial paper	0	(714)
Payments on borrowings from credit facilities	0	(1,919)
Proceeds from borrowings on credit facilities	0	1,916
Payments on long-term borrowings and debt extinguishment costs	0	(1,000)
Proceeds from long-term borrowings, net of debt issuance costs	0	1,683
Cash dividends paid on preferred stock	(28)	0
Net proceeds from issuance of preferred stock in connection with public offering	0	975
Net proceeds from issuance of common stock in connection with public offering	0	975
Cash used to net share settle employee equity awards	(47)	(57)
Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans	38	48
Cash provided by (used for) financing activities	(93)	1,361
Effect of foreign exchange rates on cash	(2)	(9)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	903	1,409
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	1,995	607
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	2,898	2,016
Supplemental Information
Stock-based compensation expense	94	88
Fair value of contingent consideration recorded in purchase accounting	221	0
Non-cash impact of transferred royalty rights	$ (43)	$ (45)